Related Experiment Video

Updated: May 5, 2026

Production and Testing of Antimicrobial Peptides and Their Mimics
10:32

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

453

An apolipoprotein E mimetic peptide with activities against multidrug-resistant bacteria and immunomodulatory effects

Chuan-qing Wang1, Chang-sheng Yang, Yi Yang

  • 1The Clinical Microbiology Lab, Department of Nosocomial Infection Control, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.

Journal of Peptide Science : an Official Publication of the European Peptide Society
|November 19, 2013
PubMed

Insights

A novel Apolipoprotein E (apoE) mimetic peptide, apoE23, shows potent activity against multidrug-resistant bacteria and modulates immune responses. This peptide has potential for future clinical applications in treating infections and inflammatory conditions.

Area of Science:

  • Biochemistry
  • Microbiology
  • Immunology

Background:

  • Apolipoprotein E (apoE) mimetic peptides with combined antibacterial and immunomodulatory activities are not well-established.
  • The receptor-binding region of apoE is a target for developing novel therapeutic agents.

Purpose of the Study:

  • To identify and characterize a novel apoE mimetic peptide with antibacterial and immunomodulatory properties.
  • To evaluate the efficacy of the identified peptide against multidrug-resistant bacteria and its effect on inflammatory cytokine expression.

Main Methods:

  • Synthesis and characterization of an apoE mimetic peptide (apoE23) from the apoE receptor-binding region.
  • Determination of the minimal inhibitory concentration (MIC) against multidrug-resistant Acinetobacter baumannii.
  • Assessment of apoE23's amphipathic α-helical conformation and its role in antimicrobial activity.
  • Quantification of cytokine expression (TNF-α, IL-6, IL-10) in lipopolysaccharide-induced THP-1 cells treated with apoE23.

Main Results:

  • ApoE23 demonstrated significant antibacterial effects against multidrug-resistant Acinetobacter baumannii with an MIC of 6 µg/ml.
  • The antimicrobial activity of apoE23 was correlated with its amphipathic α-helical structure.
  • ApoE23 effectively downregulated the expression of key inflammatory cytokines: tumor necrosis factor-α, interleukin-6, and interleukin-10.

Conclusions:

  • ApoE23 is a promising novel peptide with dual antibacterial and immunomodulatory functions.
  • The findings suggest apoE23's potential for clinical applications in combating multidrug-resistant infections and managing inflammatory responses.
Keywords:
antibacterial peptideapolipoprotein Eimmunomodulationmimetic peptide

More Related Videos

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium09:45

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium

Published on: May 18, 2021

2.1K
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

11.5K

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.6K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
216
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127